BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21097714)

  • 1. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
    Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
    Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
    Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
    Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
    Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
    Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
    Ruhl T; Karthaus N; Kim BS; Beier JP
    Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
    Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
    Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
    Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
    J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
    Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
    Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors.
    Rock RB; Gekker G; Hu S; Sheng WS; Cabral GA; Martin BR; Peterson PK
    J Neuroimmune Pharmacol; 2007 Jun; 2(2):178-83. PubMed ID: 18040842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
    Feng YJ; Li YY; Lin XH; Li K; Cao MH
    World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
    McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
    Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB
    Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
    Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.